Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 37.79M | € 65.92M | € 70.26M | € 72.00M | € 59.95M |
Total Assets | € 339.63M | € 344.92M | € 333.90M | € 324.82M | € 319.19M |
Total Debt | € 139.42M | € 146.88M | € 159.26M | € 162.56M | € 167.98M |
Net Debt | € 101.64M | € 80.96M | € 89.01M | € 90.56M | € 108.04M |
Total Liabilities | € 224.10M | € 239.07M | € 235.18M | € 229.75M | € 227.17M |
Stockholders Equity | € 115.60M | € 105.79M | € 98.57M | € 94.80M | € 92.08M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |